83 related articles for article (PubMed ID: 3493701)
1. Extravascular plasminogen activator and inhibitor activities detected at the site of a chronic mycobacterial-induced inflammation.
O'Rourke J; Wang WP; Donnelly L; Wang E; Kreutzer DL
Am J Pathol; 1987 Feb; 126(2):334-42. PubMed ID: 3493701
[TBL] [Abstract][Full Text] [Related]
2. Regulation of anterior chamber fibrinolysis.
O'Rourke J; Moore M; Kreutzer DL
Curr Eye Res; 1985 May; 4(5):569-78. PubMed ID: 2410195
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
Hayashi K; Nakashima Y; Sueishi K; Tanaka K
Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
[TBL] [Abstract][Full Text] [Related]
4. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
[TBL] [Abstract][Full Text] [Related]
5. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
6. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
8. Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.
Dong Q; Zhou MH; Subbarao V; Ts'ao CH
Br J Exp Pathol; 1988 Oct; 69(5):685-95. PubMed ID: 3143395
[TBL] [Abstract][Full Text] [Related]
9. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
Juhan-Vague I; Vague P; Alessi MC; Badier C; Valadier J; Aillaud MF; Atlan C
Diabete Metab; 1987 Jul; 13(3 Pt 2):331-6. PubMed ID: 3115843
[TBL] [Abstract][Full Text] [Related]
10. [Tissue plasminogen activator and plasminogen activator inhibitor in aqueous humor].
Giedrojć J; Stankiewicz A; Walkowiak M; Galar M; Bielawiec M
Klin Oczna; 1996; 98(4):283-5. PubMed ID: 9463119
[TBL] [Abstract][Full Text] [Related]
11. [Tissue plasminogen activator (t-PA) in aqueous humor of patients with cataract].
Kotschy M; Kałuzny J; Kaniasty M; Zekanowska E; Kropińska E
Klin Oczna; 1996 Mar; 98(3):201-3. PubMed ID: 9019589
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.
Gross JL; Behrens DL; Mullins DE; Kornblith PL; Dexter DL
Cancer Res; 1988 Jan; 48(2):291-6. PubMed ID: 3121170
[TBL] [Abstract][Full Text] [Related]
13. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.
Gelehrter TD; Sznycer-Laszuk R
J Clin Invest; 1986 Jan; 77(1):165-9. PubMed ID: 2418059
[TBL] [Abstract][Full Text] [Related]
14. [Plasminogen activator and PAI. Detection in aqueous humor of the human eye].
Steinkamp GW; Hattenbach LO; Heider HW; Scharrer I
Ophthalmologe; 1993 Feb; 90(1):73-5. PubMed ID: 8443455
[TBL] [Abstract][Full Text] [Related]
15. Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines.
Sitrin RG; Gyetko MR; Kole KL; McKeever P; Varani J
Cancer Res; 1990 Aug; 50(16):4957-61. PubMed ID: 2379161
[TBL] [Abstract][Full Text] [Related]
16. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
Michel JB; Quertermous T
J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
[TBL] [Abstract][Full Text] [Related]
17. Urokinase-type plasminogen activator in human aqueous humor.
Bernatchez SF; Tabatabay C; Belin D
Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2687-92. PubMed ID: 1639615
[TBL] [Abstract][Full Text] [Related]
18. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
[TBL] [Abstract][Full Text] [Related]
19. [Anti-activator inhibitors of plasminogen].
Juhan-Vague I; Alessi MC; Aillaud MF
Ann Biol Clin (Paris); 1987; 45(2):202-6. PubMed ID: 3113299
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator and plasminogen activator inhibitor associated with granulomatous inflammation: a study with murine leprosy.
Izaki S; Hibino T; Isozaki Y; Hsu PS; Izaki M; Matsuo O
Thromb Haemost; 1984 Dec; 52(3):243-9. PubMed ID: 6397870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]